Dave Neustaedter
Direktor/Vorstandsmitglied bei G.I. Windows, Inc.
Profil
David Neustaedter, Ph.D., is a Venture Partner on the Medical Technologies team and joined the Firm in 2022.
Prior to Deerfield, Dr. Neustaedter spent seven years as a Vice President, at Medtronic Ventures and, before Medtronic’s merger with Covidien, spent a further 7 years with Covidien including five years as a Vice President of Venture Capital.
He has also held positions at Stryker Development, Leerink Swann/MEDACorp Strategy Consulting, Fletcher Spaght, and Braun Consulting.
Dr. Neustaedter holds a B.Sc.
in Cellular, Molecular, and Microbial Biology from University of Calgary, an M.B.A from Yale University, and a Ph.D.
in Molecular Biology from University of British Columbia.
Aktive Positionen von Dave Neustaedter
Unternehmen | Position | Beginn |
---|---|---|
G.I. Windows, Inc.
G.I. Windows, Inc. BiotechnologyHealth Technology G.I. Windows, Inc. develops and markets a technology which involves a series of self assembling magnets (SAMSEN) for incision less bypass procedures within the digestive system. It specializes in non-surgical bypass and nitial clinical applications. The company was founded by Christopher Thompson and Marvin Ryou and is headquartered in West Bridgewater, MA. | Direktor/Vorstandsmitglied | - |
Solace Therapeutics, Inc.
Solace Therapeutics, Inc. Medical SpecialtiesHealth Technology Solace Therapeutics, Inc. develops non-surgical treatments for common bladder disorders. It offers medical devices for stress urinary incontinence, overactive bladder, male voiding dysfunction, and lower urinary tract symptoms. The company was founded by Kevin G. Connors in 2002 and is headquartered in Framingham, MA. | Direktor/Vorstandsmitglied | - |
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Private Equity Investor | 01.09.2022 |
Ehemalige bekannte Positionen von Dave Neustaedter
Unternehmen | Position | Ende |
---|---|---|
Point Judith Management Co LLC.
Point Judith Management Co LLC. Investment ManagersFinance Point Judith Management Co LLC (Point Judith Capital Partner) is a venture capital firm founded in 2001 by David Martirano and Gina Raimondo. The firm is headquartered in Boston, Massachusetts. | Corporate Officer/Principal | 30.06.2008 |
Semma Therapeutics, Inc.
Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - |
MD Revolution, Inc.
MD Revolution, Inc. Packaged SoftwareTechnology Services MD Revolution, Inc. engages in the provision of a digital care management platform. Its product platform include care management features, clinical tools, patient engagement tools, and integration. The firm solutions also include Chronic Care Management; Remote Patient Monitoring; Behavioral Health Integration; Annual Wellness Visits; Transitional Care Management; Whole Person Care; Clinical Care Teams; And Care Program Design. The company was founded by Samir Damani in 2011 and is headquartered in Solana Beach, CA. | Direktor/Vorstandsmitglied | - |
SetPoint Medical Corp.
SetPoint Medical Corp. Medical/Nursing ServicesHealth Services SetPoint Medical Corp. operates as a biomedical technology company, which engages in the development of therapies for patients with inflammatory autoimmune diseases such as rheumatoid arthritis and Crohn?s disease. The company was founded by Kevin J. Tracey, Shaw H. Warren, and James W. Broderick in 2006 and is headquartered in Santa Clarita, CA. | Direktor/Vorstandsmitglied | - |
PQ Bypass, Inc.
PQ Bypass, Inc. Electronic Equipment/InstrumentsElectronic Technology PQ Bypass, Inc. develops novel procedure for the treatment of peripheral vascular diseases. It offers an approach for achieving a bypass of the femoral artery that is designed to match the performance and safety of an invasive surgery for long segment occlusions. The company was founded by Richard Heuser and James D. Joye in 2009 and is headquartered in Sunnyvale, CA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Dave Neustaedter
University of British Columbia | Doctorate Degree |
Yale University | Masters Business Admin |
University of Calgary | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 10 |
---|---|
Point Judith Management Co LLC.
Point Judith Management Co LLC. Investment ManagersFinance Point Judith Management Co LLC (Point Judith Capital Partner) is a venture capital firm founded in 2001 by David Martirano and Gina Raimondo. The firm is headquartered in Boston, Massachusetts. | Finance |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Finance |
Fletcher Spaght, Inc.
Fletcher Spaght, Inc. Miscellaneous Commercial ServicesCommercial Services Fletcher Spaght, Inc. provides strategy consulting and market research services. It offers finance assistance to new ventures in the fields of health care and high technology. The firm also has a venture capital firm that accepts equity interest in a client in place of consulting fees. The company was founded in 1983 by John Fletcher and is headquartered in Boston, MA. | Commercial Services |
PQ Bypass, Inc.
PQ Bypass, Inc. Electronic Equipment/InstrumentsElectronic Technology PQ Bypass, Inc. develops novel procedure for the treatment of peripheral vascular diseases. It offers an approach for achieving a bypass of the femoral artery that is designed to match the performance and safety of an invasive surgery for long segment occlusions. The company was founded by Richard Heuser and James D. Joye in 2009 and is headquartered in Sunnyvale, CA. | Electronic Technology |
SetPoint Medical Corp.
SetPoint Medical Corp. Medical/Nursing ServicesHealth Services SetPoint Medical Corp. operates as a biomedical technology company, which engages in the development of therapies for patients with inflammatory autoimmune diseases such as rheumatoid arthritis and Crohn?s disease. The company was founded by Kevin J. Tracey, Shaw H. Warren, and James W. Broderick in 2006 and is headquartered in Santa Clarita, CA. | Health Services |
MD Revolution, Inc.
MD Revolution, Inc. Packaged SoftwareTechnology Services MD Revolution, Inc. engages in the provision of a digital care management platform. Its product platform include care management features, clinical tools, patient engagement tools, and integration. The firm solutions also include Chronic Care Management; Remote Patient Monitoring; Behavioral Health Integration; Annual Wellness Visits; Transitional Care Management; Whole Person Care; Clinical Care Teams; And Care Program Design. The company was founded by Samir Damani in 2011 and is headquartered in Solana Beach, CA. | Technology Services |
Semma Therapeutics, Inc.
Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Health Technology |
G.I. Windows, Inc.
G.I. Windows, Inc. BiotechnologyHealth Technology G.I. Windows, Inc. develops and markets a technology which involves a series of self assembling magnets (SAMSEN) for incision less bypass procedures within the digestive system. It specializes in non-surgical bypass and nitial clinical applications. The company was founded by Christopher Thompson and Marvin Ryou and is headquartered in West Bridgewater, MA. | Health Technology |
Solace Therapeutics, Inc.
Solace Therapeutics, Inc. Medical SpecialtiesHealth Technology Solace Therapeutics, Inc. develops non-surgical treatments for common bladder disorders. It offers medical devices for stress urinary incontinence, overactive bladder, male voiding dysfunction, and lower urinary tract symptoms. The company was founded by Kevin G. Connors in 2002 and is headquartered in Framingham, MA. | Health Technology |
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Finance |